The Ganesha Lab Biohunt Summit Miami 2022: a first-class event
Over 250 people attended our event, which sought to make the potential of Latin American biotech startups visible in the U.S. market and generate connections to transform science into a good business.
The venue served as a perfect place for attendees to connect and build the initial bonds during the brunch that kicked off the event, to then be followed by the presentations of the startups in the dolphin tanks.
This session became, without a doubt, one of the most attractive activities for investors, who came from Boston, New York, San Francisco and even from other Latin American countries. They were impressed by the outstanding presentations of the entrepreneurs, enabling the first connections and individual meetings. The remarkable networking translated into more than 150 initial meetings with subsequent follow-ups.
To culminate an exceptional first day, all attendees shared a VIP dinner at exclusive restaurants in Miami, where they were also able to continue making connections, not only between investors and entrepreneurs but also among peers.
During the second day of the Biohunt Summit, we wanted to promote female founders for biotech ventures. Laura Macció, CEO of metaBIX Biotech; and Anastasia Gutkevich, CEO of Bifidice, traveled to Boston to represent Latin American female empowerment. They met with the association Latinos in Bio, presented in the activity Drinks & Demo Tables at Cambridge Venture Café to finalize their participation in pitching at the Biotech Innovation Bridge, an activity that connected Boston and Miami ecosystems around the theme “Biotech happens everywhere”.
Undoubtedly, the Biohunt Summit had the impact we set out to accomplish and will become the place to meet for entrepreneurs and investors searching to impact the future, especially if we consider that the networking translated into more than 180 initial meetings, more than 70 follow-up scheduled encounters, 45 investment opportunities and 152 other business opportunities created.